Blafar Injectable Hydrogels
Injectable Hydrogels for Translational Medicine
Blafar provides a series of advanced injectable hydrogel systems as the optimal microenvironments for customised cell culture and regenerative medicine.
These biocompatible injectable hydrogels are based on precisely designed functionalised extracellular matrix (ECM)-based biopolymers and/or our unique biocompatible synthetic PEG-based polymers. Blafar hydrogel precursors can be injected with minimal invasion and rapidly crosslinked in situ by UV irradiation or click chemistry.
Blafar hydrogels display a spectrum of substrate options and physical properties depending on the functional group densities and substrate concentrations designed specifically to meet requirements of a wide range of applications.
Advantages of Blafar Hydrogel
Blafar hydrogel components (naturally derived or synthetic) mimic critical features of the natural ECM environment.
Controlled degradability of Blafar hydrogel in a tunable manner without generating any toxic byproducts.
Blafar hydrogel system modification to accommodate specific application requirements.
Saleable manufacturing capacity (lab scale to pilot scale).
Blafar hydrogels can be crosslinked in situ, matching any irregular defects with minimal invasion to adhere to the surroundings during formation.
- Wound care
- Cartilage repair
- Orthopedics and anesthetics
- Cell/drug/bioactive delivery platform
- Tissue adhesive
- 3D culture platform
- 3D printing
Which Blafar Hydrogel is ideal for you?
The hydrogel is flexible in respect to gelation time, crosslink density, functionalisation and degradation; formed by any combination of Thiol modified ECM-based biopolymers (e.g. hyaluronic acid, gelatin, chondroitin sulfate) crosslinking with vinyl modified ECM-based biopolymers or multi-branched synthetic polymers with acrylate end functional groups.